siagoside has been researched along with Acute Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coleman, WP; Geisler, FH; Grieco, G; Poonian, D | 2 |
| Bracken, MB; Fehlings, MG | 1 |
1 trial(s) available for siagoside and Acute Disease
| Article | Year |
|---|---|
The Sygen multicenter acute spinal cord injury study.
Topics: Acute Disease; Adolescent; Adult; Aged; Double-Blind Method; Female; G(M1) Ganglioside; Humans; Logistic Models; Male; Middle Aged; Neuroprotective Agents; Prospective Studies; Recovery of Function; Spinal Cord Injuries; Treatment Outcome | 2001 |
3 other study(ies) available for siagoside and Acute Disease
| Article | Year |
|---|---|
Siagoside. GM1, Sygen.
Topics: Acute Disease; Animals; Antiparkinson Agents; Brain Ischemia; Drugs, Investigational; G(M1) Ganglioside; Humans; Neuroprotective Agents; Parkinson Disease; Stroke | 1999 |
Recruitment and early treatment in a multicenter study of acute spinal cord injury.
Topics: Acute Disease; Adolescent; Adult; Aged; Decompression, Surgical; Female; G(M1) Ganglioside; Humans; Male; Middle Aged; Neuroprotective Agents; North America; Patient Selection; Randomized Controlled Trials as Topic; Retrospective Studies; Spinal Cord Injuries; Time Factors | 2001 |
Summary statement: the Sygen(GM-1 ganglioside) clinical trial in acute spinal cord injury.
Topics: Acute Disease; G(M1) Ganglioside; Humans; Multicenter Studies as Topic; Neuroprotective Agents; Randomized Controlled Trials as Topic; Spinal Cord Injuries; Treatment Outcome | 2001 |